Health care conversations have outgrown the concept of transformation; what we need now is a revolution, driven by the capabilities of cutting-edge technology.

Through the Stop Rabies program, Boehringer Ingelheim is contributing towards achieving the global Zero by 30 goal to end human deaths from dog-mediated rabies infections by 2030.

The strong market response underscores the surging demand for WELL’s people-first approach for delivering healthier, more resilient spaces for everyone…

In honor of Mental Health Awareness Month, we’re proud to share that 100% of our employees have access to mental health resources and financial education.

The Skin Cancer Foundation cites that 1 in 5 Americans will develop skin cancer by age 70. Taking charge of our skincare is a vital step to protecting the skin; from daily sunscreen use on face and body to reapplication for those long days outside.

The International WELL Building Institute (IWBI), the global authority for advancing healthy buildings, organizations and communities, today announced rapid uptake of the streamlined pathway for projects that pursue both LEED and WELL certification.

In this episode of the Medtronic Open Book series, Latimore unabashedly shares more about his life and long journey to finding some relief from his overactive bladder symptoms.

Improving access to medicines and healthcare requires a continued effort to develop new evidence-based solutions that address unmet needs.

The Healthcare Plastics Recycling Council (HPRC) is thrilled to announce the publication of its inaugural Impact Report for 2024.

One team. One mission. One customer segment. Aflac’s hotline for newly diagnosed cancer patients proves that going deeper is the key to meaningful support.

Alex was born with a quarter-sized hole in his heart and after experiencing irregular heart rhythms in his 20s, he received his device. Join us in the latest episode of Open Book as we learn how he continues to help people in his career as a nurse,…

Listen now to learn how new approaches to care and performance are helping service members and their families build resilience, sustain readiness, and thrive during and after service.

Elanco Animal Health Incorporated today released a new report highlighting the significance of America's Itchy Dogs and the impact itch has on dogs, their owners, and veterinarians.

In order to achieve lasting impact, we have expanded a number of our access programs to go beyond the product by incorporating Health System Strengthening and Capacity Building efforts.

At Gilead, we’re advancing new ways to help end the HIV epidemic by delivering innovative therapies to those who need them most. In our latest episode of The Centrifuge Sessions, Magdeleine Hung, Director of Protein Therapeutics, shares insights on…

In 2020, we committed to launching eight Access to Medicines programs by 2025, aimed at providing treatments to underserved populations worldwide via customized, localized models conducted with partner organizations, and tailored to meet specific…

The rise of highly pathogenic avian influenza (HPAI), particularly the H5N1 strain, presents serious challenges to worker safety across several industries.

We’re proud to share that “The Adventure Jar,” a children’s book supporting families impacted by metastatic breast cancer (MBC), has received two 2025 Bronze Anvil Awards from the Public Relations Society of America (PRSA).

In this episode of the Medtronic series Open Book, Manny shares how spina bifida impacts his life in unseen ways.

Subaru of America, Inc. today announced a major milestone, marking the tenth consecutive year of partnering with The Leukemia & Lymphoma Society® (LLS) as part of its Subaru Loves to Care® initiative.

When Emma was diagnosed with triple-negative breast cancer, she didn't let it define her. There are so many ways cancer steals possibility, but at Gilead, we’re helping take it back.

GileadNews: We’re joining with Kite Pharma to announce the presentation of transformative cancer research at this year’s American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA) annual meetings.

An international alliance of humanitarian and medical organizations is announcing the launch of a new initiative to protect kidney and dialysis patients in crisis settings around the world.  

At Teva, we are all in for better health. Increasing access to quality medicines is fundamental to improving the health of patients and the success of our business.

Artificial intelligence allows us to examine that data to identify certain types of heart disease sooner and get personalized treatment to the patient faster.